Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Development and commercialization agreement reached for velusetrag for gastroparesis

Oct. 4, 2012

Ipsen provides update on hemophilia product agreement with Inspiration Biopharmaceuticals

Oct. 4, 2012

Ablynx and Merck & Co. enter collaboration for Nanobody candidates

Oct. 4, 2012

Janssen licenses rights to Astellas' oral JAK inhibitor

Oct. 3, 2012

GTx sells Fareston

Oct. 3, 2012

Shionogi and Kotobuki Pharmaceutical sign license agreement for cholesterol absorption inhibitor

Oct. 2, 2012

Bayer HealthCare joins forces with Evotec on endometriosis

Oct. 2, 2012

Osiris Therapeutics regains rights to Prochymal and Chondrogen

Oct. 1, 2012

Merck & Co. returns vernakalant rights

Sep. 28, 2012

Pfizer and Acura Pharmaceuticals terminate license agreement

Sep. 28, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...